Cathepsin B has been implicated in numerous pathobiological processes.
In order to study its interactions with other proteins implicated in
these processes, quantities of functional recombinant cathepsin B are
needed. Therefore, we expressed recombinant human procathepsin B in ma
mmalian cells (BSC-1 monkey kidney cells and HeLa human cervical carci
noma cells) using a vaccinia virus expression system. The recombinant
human procathepsin B appeared to be authentic and expressed in its nat
ive conformation as indicated by. (1) N-terminal sequencing; (2) molec
ular size; (3) processing intracellularly to mature double-chain cathe
psin B; (4) in vitro cleavage by pepsin to mature cathepsin B coincide
nt with appearance of activity against a selective synthetic substrate
; and (5) substrate/inhibitor profiles. This is the first report of th
e expression of functional recombinant human procathepsin B in mammali
an cells. We also report a single-step immunoaffinity purification pro
cedure for the isolation of electrophoretically pure proenzyme. By the
methodologies described, human procathepsin B can now be obtained in
high yield. This should facilitate studies of its interactions with pr
otease inhibitors, other proteases, extracellular matrices, cell-surfa
ce proteins and biological substrates that may be of relevance to the
pathobiological functions of this enzyme.